Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 236

1.

Highly specific enrichment of rare nucleic acid fractions using Thermus thermophilus argonaute with applications in cancer diagnostics.

Song J, Hegge JW, Mauk MG, Chen J, Till JE, Bhagwat N, Azink LT, Peng J, Sen M, Mays J, Carpenter EL, van der Oost J, Bau HH.

Nucleic Acids Res. 2019 Dec 12. pii: gkz1165. doi: 10.1093/nar/gkz1165. [Epub ahead of print]

PMID:
31828328
2.

Use of Routine Environmental Monitoring Data to Establish a Dose-based Compliance System for a Low-level Radioactive Waste Disposal Site.

Rood AS, Grogan HA, Mohler HJ, Rocco JR, Caffrey EA, Mangini C, Cartwright J, Matthews T, Shaw C, Packard ME, Till JE.

Health Phys. 2020 Jan;118(1):1-17. doi: 10.1097/HP.0000000000001116.

PMID:
31703016
3.

Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study.

Bagley SJ, Nabavizadeh SA, Mays JJ, Till JE, Ware JB, Levy S, Sarchiapone W, Hussain J, Prior T, Guiry S, Christensen T, Yee SS, Nasrallah MP, Morrissette JJD, Binder ZA, O'Rourke DM, Cucchiara AJ, Brem S, Desai AS, Carpenter EL.

Clin Cancer Res. 2020 Jan 15;26(2):397-407. doi: 10.1158/1078-0432.CCR-19-2533. Epub 2019 Oct 30.

PMID:
31666247
4.

Reconstruction of atmospheric concentrations of enriched uranium from the former Apollo facility, Apollo, Pennsylvania, USA.

Rood AS, Grogan HA, Mohler HJ, Meyer KR, Voillequé PG, Till JE.

J Environ Radioact. 2020 Jan;211:106045. doi: 10.1016/j.jenvrad.2019.106045. Epub 2019 Oct 16.

PMID:
31629194
5.

Response to Letter by Moghissi and Calderone.

Shore RE, Beck HL, Boice JD Jr, Caffrey EA, Davis S, Grogan HA, Mettler FA, Preston RJ, Till JE, Wakeford R, Walsh L, Dauer LT.

Health Phys. 2019 Aug;117(2):224-225. doi: 10.1097/HP.0000000000001107. No abstract available.

PMID:
31219905
6.

Reply to Comment on 'Implications of recent epidemiologic studies for the linear nonthreshold model and radiation protection'.

Shore RE, Beck HL, Boice JD, Caffrey EA, Davis S, Grogan HA, Mettler FA, Preston RJ, Till JE, Wakeford R, Walsh L, Dauer LT.

J Radiol Prot. 2019 Jun;39(2):655-659. doi: 10.1088/1361-6498/ab077f. Epub 2019 May 24. No abstract available.

PMID:
31125317
7.

Recent Epidemiologic Studies and the Linear No-Threshold Model For Radiation Protection-Considerations Regarding NCRP Commentary 27.

Shore RE, Beck HL, Boice JD Jr, Caffrey EA, Davis S, Grogan HA, Mettler FA Jr, Preston RJ, Till JE, Wakeford R, Walsh L, Dauer LT.

Health Phys. 2019 Feb;116(2):235-246. doi: 10.1097/HP.0000000000001015.

PMID:
30585971
8.

Asbestos Exposure and Mesothelioma Mortality among Atomic Veterans.

Till JE, Beck HL, Boice JD, Mohler HJ, Mumma MT, Aanenson JW, Grogan HA.

Int J Radiat Biol. 2018 Dec 4:1-15. doi: 10.1080/09553002.2018.1551641. [Epub ahead of print]

PMID:
30513236
9.

Dosimetry Associated with Veterans who Participated in Nuclear Weapons Testing.

Till JE, Beck HL, Aanenson JW, Grogan HA, Mohler HJ, Mohler SS, Voillequé PG.

Int J Radiat Biol. 2018 Dec 4:1-30. doi: 10.1080/09553002.2018.1551639. [Epub ahead of print]

PMID:
30513229
10.

Dosimetry and uncertainty approaches for the million person study of low-dose radiation health effects: overview of the recommendations in NCRP Report No. 178.

Dauer LT, Bouville A, Toohey RE, Boice JD Jr, Beck HL, Eckerman KF, Hagemeyer D, Leggett RW, Mumma MT, Napier B, Pryor KH, Rosenstein M, Schauer DA, Sherbini S, Stram DO, Thompson JL, Till JE, Yoder RC, Zeitlin C.

Int J Radiat Biol. 2018 Nov 19:1-10. doi: 10.1080/09553002.2018.1536299. [Epub ahead of print]

PMID:
30452303
11.

Implications of recent epidemiologic studies for the linear nonthreshold model and radiation protection.

Shore RE, Beck HL, Boice JD, Caffrey EA, Davis S, Grogan HA, Mettler FA, Preston RJ, Till JE, Wakeford R, Walsh L, Dauer LT.

J Radiol Prot. 2018 Sep;38(3):1217-1233. doi: 10.1088/1361-6498/aad348. Epub 2018 Jul 13.

PMID:
30004025
12.

Understanding and communicating radiation dose and risk from cone beam computed tomography in dentistry.

Aanenson JW, Till JE, Grogan HA.

J Prosthet Dent. 2018 Sep;120(3):353-360. doi: 10.1016/j.prosdent.2018.01.008. Epub 2018 Apr 30. Review.

PMID:
29724555
13.

E-cadherin and K-ras: implications of a newly developed model of gastric cancer.

Till JE, Yoon SS, Ryeom S.

Oncoscience. 2017 Nov 28;4(11-12):162-163. doi: 10.18632/oncoscience.379. eCollection 2017 Nov. No abstract available.

14.

Oncogenic KRAS and p53 Loss Drive Gastric Tumorigenesis in Mice That Can Be Attenuated by E-Cadherin Expression.

Till JE, Yoon C, Kim BJ, Roby K, Addai P, Jonokuchi E, Tang LH, Yoon SS, Ryeom S.

Cancer Res. 2017 Oct 1;77(19):5349-5359. doi: 10.1158/0008-5472.CAN-17-0061. Epub 2017 Jul 31.

15.

A review of dosimetry used in epidemiological studies considered to evaluate the linear no-threshold (LNT) dose-response model for radiation protection.

Till JE, Beck HL, Grogan HA, Caffrey EA.

Int J Radiat Biol. 2017 Oct;93(10):1128-1144. doi: 10.1080/09553002.2017.1337280. Epub 2017 Jul 7. Review.

PMID:
28685638
16.

Red Bone Marrow and Male Breast Doses for a Cohort of Atomic Veterans.

Beck HL, Till JE, Grogan HA, Aanenson JW, Mohler HJ, Mohler SS, Voillequé PG.

Radiat Res. 2017 Feb;187(2):221-228. doi: 10.1667/RR14458.1. Epub 2017 Jan 30.

PMID:
28135126
17.

Tumor vessel normalization after aerobic exercise enhances chemotherapeutic efficacy.

Schadler KL, Thomas NJ, Galie PA, Bhang DH, Roby KC, Addai P, Till JE, Sturgeon K, Zaslavsky A, Chen CS, Ryeom S.

Oncotarget. 2016 Oct 4;7(40):65429-65440. doi: 10.18632/oncotarget.11748.

18.

Mortality among military participants at the 1957 PLUMBBOB nuclear weapons test series and from leukemia among participants at the SMOKY test.

Caldwell GG, Zack MM, Mumma MT, Falk H, Heath CW, Till JE, Chen H, Boice JD.

J Radiol Prot. 2016 Sep;36(3):474-489. Epub 2016 Jun 29.

19.

Dose reconstruction for the million worker study: status and guidelines.

Bouville A, Toohey RE, Boice JD Jr, Beck HL, Dauer LT, Eckerman KF, Hagemeyer D, Leggett RW, Mumma MT, Napier B, Pryor KH, Rosenstein M, Schauer DA, Sherbini S, Stram DO, Thompson JL, Till JE, Yoder C, Zeitlin C.

Health Phys. 2015 Feb;108(2):206-20. doi: 10.1097/HP.0000000000000231.

20.

Comparison of the MACCS2 atmospheric transport model with Lagrangian puff models as applied to deterministic and probabilistic safety analysis.

Till JE, Rood AS, Garzon CD, Lagdon RH Jr.

Health Phys. 2014 Sep;107(3):213-30. doi: 10.1097/HP.0000000000000102.

PMID:
25068959
21.
22.

Military participants at U.S. Atmospheric nuclear weapons testing--methodology for estimating dose and uncertainty.

Till JE, Beck HL, Aanenson JW, Grogan HA, Mohler HJ, Mohler SS, Voillequé PG.

Radiat Res. 2014 May;181(5):471-84. doi: 10.1667/RR13597.1. Epub 2014 Apr 23.

23.

Lauriston S. Taylor lecture on radiation protection and measurements: when does risk assessment get fuzzy?

Till JE.

Health Phys. 2014 Feb;106(2):148-61. doi: 10.1097/HP.0000000000000023.

PMID:
24378488
24.

A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. 1961.

Till JE, McCulloch EA.

Radiat Res. 2012 Aug;178(2):AV3-7. No abstract available.

PMID:
22870977
25.

An integrated approach to data management, risk assessment, and decision making.

Till JE, Grogan HA, Mohler HJ, Rocco JR, Rood AS, Mohler SS.

Health Phys. 2012 Apr;102(4):367-77. doi: 10.1097/HP.0b013e318239c022.

PMID:
22378197
26.

RACER: dynamic use of environmental measurement data for decision making and communication.

Mohler HJ, Grogan HA, Rocco JR, Kiefer RF, Till JE.

Health Phys. 2012 Feb;102 Suppl 1:S13-21. doi: 10.1097/HP.0b013e318231aa62.

PMID:
22249468
27.

A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. 1961.

Till JE, McCulloch EA.

Radiat Res. 2011 Feb;175(2):145-9. Epub 2010 Dec 8. No abstract available.

PMID:
21268707
28.

Genetic and phenotypic analysis of flagellar assembly mutants in Chlamydomonas reinhardtii.

Iomini C, Till JE, Dutcher SK.

Methods Cell Biol. 2009;93:121-43. doi: 10.1016/S0091-679X(08)93007-7. Epub 2009 Dec 4.

29.

Reconstruction of atmospheric concentrations and deposition of uranium and decay products released from the former uranium mill at Uravan, Colorado.

Rood AS, Voillequé PG, Rope SK, Grogan HA, Till JE.

J Environ Radioact. 2008 Aug;99(8):1258-78. doi: 10.1016/j.jenvrad.2008.03.009. Epub 2008 Apr 29.

PMID:
18448213
30.
31.

Practical and scientifically based approaches for cleanup and site restoration.

Till JE, McBaugh D.

Health Phys. 2005 Nov;89(5):583-8.

PMID:
16217202
32.

Perspectives on the properties of stem cells.

McCulloch EA, Till JE.

Nat Med. 2005 Oct;11(10):1026-8. Review. No abstract available.

PMID:
16211027
33.

A Canadian perspective.

Till JE.

PLoS Med. 2005 Mar;2(3):e83. Epub 2005 Mar 29. No abstract available.

34.

Application of NCRP air screening factors for evaluating both routine and episodic radionuclide releases to the atmosphere.

Mohler HJ, Meyer KR, Grogan HA, Aanenson JW, Till JE.

Health Phys. 2004 Feb;86(2):135-44.

PMID:
14744046
35.
36.

Success factors for open access.

Till JE.

J Med Internet Res. 2003 Jan-Mar;5(1):e1.

37.
38.

Risks to the public from historical releases of radionuclides and chemicals at the Rocky Flats Environmental Technology Site.

Till JE, Rood AS, Voillequé PG, McGavran PD, Meyer KR, Grogan HA, Sinclair WK, Aanenson JW, Meyer HR, Mohler HJ, Rope SK, Case MJ.

J Expo Anal Environ Epidemiol. 2002 Sep;12(5):355-72.

40.

Stochastic estimates of exposure and cancer risk from carbon tetrachloride released to the air from the rocky flats plant.

Rood AS, McGavran PD, Aanenson JW, Till JE.

Risk Anal. 2001 Aug;21(4):675-95.

PMID:
11726020
41.

Peer review in a post-eprints world: a proposal.

Till JE.

J Med Internet Res. 2000 Jul-Sep;2(3):E14.

42.

Ethical issues in qualitative research on internet communities.

Eysenbach G, Till JE.

BMJ. 2001 Nov 10;323(7321):1103-5. Review. No abstract available.

43.

Public involvement in science and decision making.

Till JE, Meyer KR.

Health Phys. 2001 Apr;80(4):370-8.

PMID:
11281205
44.
45.
46.

What attitudes and beliefs underlie patients' decisions about participating in chemotherapy trials?

Sutherland HJ, da Cunha R, Lockwood GA, Till JE.

Med Decis Making. 1998 Jan-Mar;18(1):61-9.

PMID:
9456210
47.

An introduction to the framework project.

Till JE.

Cancer Prev Control. 1997 Aug;1(3):192-5.

PMID:
9765744
48.
50.

The Internet: a modern Pandora's box?

Mayer M, Till JE.

Qual Life Res. 1996 Dec;5(6):568-71.

PMID:
8993102

Supplemental Content

Support Center